A single‐center retrospective study of 15 patients with BRAF V600E mutation and LCH showed that conventional doses of cytarabine with lower doses of 2‐CdA appeared to be unable to eradicate LCH progenitor cells. This evidence concerns the gene BRAF and Langerhans cell histiocytosis.